global glp-1 obesity drug market size forecast 2030 Market: the rapid growth of the diabetes and drugs The outlook for obesity from
Description
Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
and by six months, it will contribute to 'healthy weight management'
2c, Supplementary Fig
[DOI] [PubMed] [Google Scholar] 70.Rangaswami J., Bhalla V., Blair J.E.A., Chang T.I., Costa S., Krista L.L., Lerma E.V., Mezue K., Molitch M., Mullens W., et al
Long-Term Data Is Not Available These medications are newer and without long-term data
The FDA reports that the drug can cause thyroid tumors in rats
